Association of increased QTc interval with the cardiometabolic syndrome

Journal of Clinical Hypertension

Volumn 12, Issue 4, 2010, Pages 315-320

  Grandinetti, Andrew ^a   Chow, Dominic C ^b   Miyasaki, Marc ^b   Low, Phillip ^a  

^a Department of Public Health Sciences ^*  (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOMETABOLIC DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; ETHNIC DIFFERENCE; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QT INTERVAL; QTC INTERVAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HAWAII; HUMANS; LONG QT SYNDROME; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POPULATION SURVEILLANCE; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 77952501821     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00224.x     Document Type: Article

References (29)

1. Schouten EG, Dekker JM, Meppelink P. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991, 84(4):1516-1523.
2. Moss AJ, Schwartz PJ, Crampton RS. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991, 84(3):1136-1144.
3. Bednar MM, Harrigan EP, Anziano RJ. The QT interval. Prog Cardiovasc Dis 2001, 5(Suppl 1):1-45.
4. Al-Khatib SM, LaPointe NM, Kramer JM. What clinicians should know about the QT interval. JAMA 2003, 289(16):2120-2127.
5. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993, 72(6):23B-25B.
6. Moller M. QT interval in relation to ventricular arrhythmias and sudden cardiac death in postmyocardial infarction patients. Acta Med Scand 1981, 210(1-2):73-77.
7. Peters RW, Byington RP, Barker A. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group. J Clin Epidemiol 1990, 43(2):167-172.
8. Bellavere F, Ferri M, Guarini L. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br Heart J 1988, 59(3):379-383.
9. Festa A, D'Agostino R, Rautaharju P. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol 2000, 86(10):1117-1122.
10. Dekker JM, Schouten EG, Klootwijk P. Association between QT interval and coronary heart disease in middle-aged and elderly men. The Zutphen Study. Circulation 1994, 90(2):779-785.
11. Grandinetti A, Seifried S, Mor J. Prevalence and risk factors for prolonged QTc in a multiethnic cohort in rural Hawaii. Clin Biochem 2005, 38(2):116-122.
12. Faramawi MF, Wildman RP, Gustat J. The association of the metabolic syndrome with QTc interval in NHANES III. Eur J Epidemiol 2008, 23(7):459-465.
13. Soydinc S, Davutoglu V, Akcay M. Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispersion. Ann Noninvasive Electrocardiol 2006, 11(4):313-317.
14. Kaholokula JK, Haynes SN, Grandinetti A. Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes. J Behav Med 2003, 26(5):435-458.
15. Hidvegi T, Hetyesi K, Biro L. Education level and clustering of clinical characteristics of metabolic syndrome. Diabetes Care 2001, 24(11):2013-2015.
16. Grundy SM, Brewer HB, Cleeman JI. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004, 24(2):e13-e18.
17. Bazett H. An analysis of the time-relations of electrocardiograms. Heart 1920, 7:353-370.
18. Grandinetti A, Chang HK, Theriault A. Metabolic syndrome in a multiethnic population in rural Hawaii. Ethn Dis 2005, 15(2):233-237.
19. Stramba-Badiale M, Locati EH, Martinelli A. Gender and the relationship between ventricular repolarization and cardiac cycle length during 24-h Holter recordings. Eur Heart J 1997, 18(6):1000-1006.
20. Merri M, Benhorin J, Alberti M. Electrocardiographic quantitation of ventricular repolarization. Circulation 1989, 80(5):1301-1308.
21. Pham TV, Rosen MR. Sex, hormones, and repolarization. Cardiovasc Res 2002, 53(3):740-751.
22. Valverde ER, Biagetti MO, Bertran GR. Developmental changes of cardiac repolarization in rabbits: implications for the role of sex hormones. Cardiovasc Res 2003, 57(3):625-631.
23. Kaab S, Pfeufer A, Hinterseer M. Long QT syndrome. Why does sex matter? Z Kardiol 2004, 93(9):641-645.
24. Dekker JM, Feskens EJ, Schouten EG. QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes 1996, 45(3):376-380.
25. Park JJ, Swan PD. Effect of obesity and regional adiposity on the QTc interval in women. Int J Obes Relat Metab Disord 1997, 21(12):1104-1110.
26. Stehouwer CD, Nauta JJ, Zeldenrust GC. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992, 340(8815):319-323.
27. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40(4):405-412.
28. Brownlee M, Cerami A, Vlassara H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 1988, 4(5):437-451.
29. Anderson ME, Al-Khatib SM, Roden DM. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management. Am Heart J 2002, 144(5):769-781.